Immunology articles for Australia

Time frame: 1 May 2025 - 30 April 2026
Count: 104

Article ‘Count’ for Immunology.

Journal Count Share
1 0.80
Proinflammatory Macrophage-Targeted Nanoparticles Rejuvenate Aged Macrophages and Their Phagocytic Capacity 0.80
1 0.09
Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase 0.09
1 0.61
The potential role of synovial T‐cell infiltration following knee joint injury in symptoms and progression to osteoarthritis 0.61
4 1.14
Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1- and Th17-dependent GVHD within the gastrointestinal tract 0.03
Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone 1.00
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study 0.03
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease 0.08
1 0.05
A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis 0.05
1 0.01
Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells 0.01
2 0.21
Generation of antigen-specific paired-chain antibodies using large language models 0.04
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells 0.17
2 0.23
Gut DNA virome enterotype dictates inflammation heterogeneity through tuning the phage-bacteria-sphingosine-intestine axis in Crohn's disease 0.14
Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolism 0.09
3 1.17
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients 0.11
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18–64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8 0.06
Long-term protection against invasive meningococcal B disease and gonococcal infection five years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study 1.00
1 0.89
Oxidative Stress as a Pathway Linking Maternal Phthalate and Bisphenol Exposure to Childhood Allergy and Lung Function: Mediation and Interaction Analyses 0.89
3 1.69
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria 0.69
Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival program 0.88
Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes 0.13
5 3.30
Allelic variation alters expression and antigen presentation of MR1 allomorphs 0.97
Inflammasome-independent IL-1β activation via staphopain A protease of Staphylococcus aureus 0.10
Prediction of KIR3DL1 and human leukocyte antigen binding 0.64
A molecular basis underpinning TRBV28+ T cell receptor recognition of MR1-antigen 0.94
Molecular basis for presentation of N-myristoylated peptides by the chicken YF1*7.1 molecule 0.65
1 0.09
uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells 0.09
2 0.27
Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice 0.25
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironment 0.02
5 1.86
DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells 0.16
The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites 0.77
Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms 0.03
Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency 0.02
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection 0.88
4 3.04
Restoration of Mucosa-Associated Invariant T-Cell Function in Healthcare-Associated Bacterial Infections Supports Recovery of Carbapenem Efficacy Against Resistant Bacteria Ex Vivo 0.14
Comparison of CD4 T cell response in Plasmodium falciparum and vivax malaria 0.89
Antibody-Dependent Neutrophil Phagocytosis of Plasmodium falciparum–Infected Erythrocytes Is Mediated by FcγRIIa 1.00
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18–55 years: a randomised, double-blind, active comparator, Phase I trial 1.00
1 0.50
Control of lymphatic pacemaking and pumping by mechanobiological signals 0.50
1 0.93
mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients. 0.93
1 1.00
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients 1.00
4 1.59
Parasites trigger epithelial cell crosstalk to drive gut–brain signalling 0.47
Targeting excessive cholesterol deposition alleviates secondary lymphoedema 0.08
Fibroblastic reticular cells direct the initiation of T cell responses via CD44 0.89
TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function 0.15
17 8.03
IFNγ blockade in Mycobacterium tuberculosis infected macaques alters the granuloma environment but not bacterial control 0.06
The GFI1–FOXO1 axis regulates NK cell maturation and function 0.90
β2 adrenergic receptors orchestrate neutrophil demargination and recruitment to the ischemic heart following myocardial infarction 0.06
CD8+ T cells sustain vaccination-induced immunity against dissemination of contained tuberculosis in immunosuppressed hosts 0.89
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion 1.00
Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer 0.80
Sideways lipid presentation by the antigen-presenting molecule CD1c 0.64
γδ T cell receptor recognition of CD1d in a lipid-independent manner 0.93
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.01
Epigenetic and transcriptional programming of murine eosinophils in the esophagus 0.10
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection 0.99
Age is an intrinsic driver of inflammatory responses to malaria 0.91
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial 0.32
Molecular basis of potent antiviral HLA-C-restricted CD8 T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope 0.19
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults 0.10
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG 0.03
Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection 0.10
13 7.40
2′--Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity 0.81
γδ T cell-derived IL-4 initiates CD8+ T cell immunity 0.95
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function 0.16
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors 0.87
DC subsets and states unraveled across human juxtatumoral and malignant tissues 0.03
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer 0.74
The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells 0.21
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor 0.03
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade 0.80
Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity 1.00
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity 0.70
PD-1 is requisite for skin TRM cell formation and specification by TGFβ 0.10
GFI1-driven transcriptional and epigenetic programs maintain CD8+ T cell stemness and persistence 1.00
1 0.59
A microRNA-based dynamic risk score for type 1 diabetes 0.59
1 0.06
More than microglial depletion: PLX5622 activates the hepatic constitutive androstane receptor to alter anesthesia and addiction 0.06
1 0.03
Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response 0.03
10 5.12
CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination 0.99
Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage 0.15
Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody 1.00
The Arabidopsis TIRome informs the design of artificial TIR (Toll/interleukin-1 receptor) domain proteins 0.28
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes 0.50
Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan 0.92
Arylsulfamates inhibit colonic Bacteroidota growth through a sulfatase-independent mechanism 0.20
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy 0.83
Induction of the ISR by AB5 subtilase cytotoxin drives type-I IFN expression in pDCs via STING activation 0.07
Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells 0.19
2 0.91
Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation 0.88
<atl>Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4 sup+/sup T cells</atl> 0.03
5 3.72
CD69 regulates the tissue dynamics of epigenetically imprinted memory CD4+ T cells 0.05
Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling 0.79
A poxvirus model reveals general correlates of antigen presentation and immunogenicity for viral CD8+ T cell epitopes 0.95
Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness 1.00
Splenic fibroblastic reticular cells orchestrate dendritic cell maturation and facilitate CD8+ T cell priming and protective memory 0.93
3 1.16
CD20 tails interact with the 14-3-3/GEF-H1 complex and microtubule network upon PKCδ phosphorylation 0.05
Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11. 0.71
A bacterial network of T3SS effectors counteracts host pro-inflammatory responses and cell death to promote infection 0.41
2 0.09
Genetic Determinants of the Complement and Coagulation Pathways in Invasive Meningococcal Disease 0.03
Abatacept Restores Dysregulated Transcriptomic and Proteomic Profile in Disorders of CTLA-4 Insufficiency 0.06
3 0.95
Iptacopan in IgA Nephropathy — Final 24-Month Data 0.03
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.03
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin 0.88
2 0.31
Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype 0.17
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.14

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.